2017 annual financial data

Supernus Pharmaceuticals 2017 Financial results

Direct answer

Revenue was 302,238,000 USD.

Operating income was 99,541,000 USD and net income was 57,284,000 USD.
Operating cash flow was 114,640,000 USD.

Get free Supernus Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
302,238,000 USD
Operating income
99,541,000 USD
Net income
57,284,000 USD
Operating cash flow
114,640,000 USD